• Home >
  • Information Technology

    • IT Management

    With pharma companies adopting an increasing number of digital tools, proper IT management and security is more critical than ever. Our coverage includes the latest in validation and implementation as well as trends in the ever-evolving landscape for IT systems.

    Articles

    PM2206-HERO-575x327-Automation
    Three priorities for re-strategizing digital transformation post-COVID
    PM2205-HERO-575x327-Culture2
    Modern manufacturing solutions can spare pharma the worst of ongoing labor shortages
    PM2112-HERO-575x327-Automation
    Advanced analytics speed time to insight, increasing return on investment
    shutterstock-1097969882
    The cyber risk to pharma manufacturers is very real and very current
    PM2109-HERO-575x327-Development
    Strategic cloud deployment is critical to achieving business and operational result
    PM2109-HERO-575x327-CoverStory
    The threats are real — and criminals are preying on pharma
    hero-image
    How incorporating IoT and telematics can prevent supply chain failures
    Hero-July-Column
    Technology advances are music to the industry's ear
    PM2008-HERO-880x500-CoverStory3
    An upbeat outlook mixed with better technology puts transformation back on track
    Screen-Shot-2020-02-17-at-1.32.53-PM
    Innovative digital tools to enhance manufacturing performance
    Screen-Shot-2019-12-02-at-12.04.13-PM
    Pharma can take steps now to prepare for the interconnected, digital supply chain
    Screen-Shot-2019-11-01-at-12.15.21-PM
    From increased connectivity throughout operations to better data analysis and automation tools, vendors have innovated solutions to transform every stage of production.
    Screen-Shot-2019-10-28-at-12.44.34-PM
    Making the switch to continuous creates new challenges for risk management and insurance coverage
    Screen-Shot-2019-10-02-at-11.16.14-AM
    Two standout industry leaders from this year's class of honorees
    data2
    “Seeing something and saying something” can be applied to the life sciences when a lack of transparency could result in a company facing stiff regulatory action.